Cart
0
Get 20% Free Customization In This Report
Buy this report from - $3690

Proteomics Market by Products and Services (Instruments, Reagents, and Services), by Application (Drug Discovery and Disease Diagnosis) - Global Opportunity Analysis and Industry Forecast, 2014-2022

LI_161677
Pages: 130
Nov 2016 | 2010 Views
face gplus_n
Author's : Deepa Tatkare
Tables: 42
Charts: 73
twit_n pr_n

Proteomics Industry Overview

Global Proteomics Market was valued at $17,988 million in 2015, and  is expected to reach $44,452 million by 2022, supported by a CAGR of 13.7%.  Proteomics is the study of the structure and functions of proteins that can be used in the drug discovery, diagnosis, and treatment of diseases. A proteome is never constant as it differs from one cell to other with time.

Proteomics is used to evaluate the rate of protein production, interaction of proteins with one another, involvement of proteins in metabolic pathways, and modification of proteins. In addition, it finds extensive applications in drug discovery, development of personalized medicines, and identification of markers for disease diagnosis, which has led to the stellar growth of the proteomics market in the past few years. With the increase in awareness regarding the benefits of personalized medicines, companies and government organizations have increased their R&D expenditure on the development of proteomics. As per the proteomics market research report, it is estimated that reagents segment will continue to lead the overall market during the forecast period.

Global Proteomics Market Segmentation

Global Proteomics Market Segmentation

Increasing popularity of personalized medicine is driving the demand for proteomic technologies

Personalized medicine is a new and better approach to healthcare based on each person's unique genetic makeup. In personalized medicine, diagnostic testing is often employed to select appropriate and optimal therapies based on the context of a patient’s genetic content or other molecular & cellular analysis. Personalized medicine finds extensive applications in the diagnosis and treatment of cancer. Proteomics is an emerging field that can make unique contributions to the field of personalized medicines. It has the advantage over genomics-based assays as it offers direct examination of the molecular machinery of cell physiology, including protein expression, sequence variations & isoforms, posttranslational modification, and protein‐protein complexes. Advances in proteomic technologies have made important contribution to the development of personalized medicine by facilitating detection of protein biomarkers, proteomics-based molecular diagnostics, as well as protein biochips & pharmacoproteomics. For instance, NantHealth, Inc. launched Genomic Proteomic Spectrometry Cancer, or GPS Cancer, which is a comprehensive molecular test that measures the proteins present in the patient’s tumor tissue, combined with whole genomic and transcriptomic sequencing of tumor and normal samples. As proteomics have important contribution in the field of personalized medicine, the impact of the driver is expected to increase during the study period with the increase in popularity of the use of personalized medicines in the treatment of cancer and neurodegenerative diseases.

Top Impacting Factors

Top Impacting Factors of Proteomics Market

 
Increasing R&D expenditure to drive the proteomics market size

Large number of organizations invest in the R&D of proteomics to understand the metabolic pathway involved in the progression of disease and the development of novel molecules for its treatment and diagnosis. In addition, organizations such as National Institutes of Health (NIH) and National Science Foundation (NSF) raise funds for various proteomics projects. For instance, in September 2016, NIH announced to fund research on “Proteomics, Immunoassay for TB Activation in HIV Patients”. In 2015, National Cancer Institute offered grants for Clinical Proteomic Tumor Analysis Consortium (CPTAC) program. The governments of European countries also take various initiatives to promote proteomics research. The European Union’s Seventh Framework Programme supports proteomics research by funding a group of proteomics researchers from European institutes for the next four years. In Australia, with assistance from government funding, the R&D expenditure on proteomics is expected to increase by 58% in 2016.

Technological advancements to drive the proteomics market

The recent technological advancements in the field of proteomics is expected to spur the proteomics market. These advancements attract the interest of pharmaceutical & biotechnology companies to venture in the field of proteomics as the convenience of use of the instrument and the outcome of the procedure have improved. For instance, technological advancements such as increased resolution of mass spectrometry helps to extract more information from minimal amount of sample. Similarly, dual mass analyzers such as LC/MS, GC/MS, FT-MS, and MALDI-TOF/TOF help to provide more detailed information about protein structure. Moreover, the development of improved liquid chromatography and gel electrophoresis have significantly helped in the protein identification and separation methods. Two-dimensional gel electrophoresis, which is based on isoelectric focusing (IEF) and denaturing polyacrylamide gel matrix for protein separation, have also been developed by scientist recently. These technological advancements are expected to propel the proteomics market.

Proteomics help to bridge the gap between the understanding of genome expression and cellular behavior

Proteomics enables the study of proteomes (the entire complement of proteins that is or can be expressed by a cell, tissue, or organism) as well as their interactions. Moreover, it characterizes protein expression profiles and identifies protein structures, localizations, activities, modifications, and interactions in physiological or pathological states. As proteins perform most biological functions, proteomics bridges the gap between the information coded in the genome sequence and cellular behavior. For instance, hepatocellular carcinoma is the third leading cause of death globalwide. Chemotherapeutic treatment is ineffective against hepatocellular carcinoma (HCC); hence, surgical removal or liver transplantation is the only treatment possible. Proteomics studies of HCC may decode the mechanisms of HCC initiation and progression, and it also has the potential to discover novel diagnostic biomarkers and therapeutic targets.

High cost of instruments

High costs of the instruments utilized in proteomics restrain the growth of the market. The cost of mass spectrometers used in the study of proteomics is approximately $20,000. The price for ion exchange chromatography with fractions collection is around $250 per sample as per the proteomics and mass spectrometry services from Cornell University. Peptide quantitation by extracted ion chromatogram costs around $160 per sample. The high price of the instruments and reagents makes it difficult for developing countries to venture in the field of proteomics. In addition, the outcome of the study and trials are not always as per expectation and the results obtained may not be satisfactory. Hence, high costs restrict the growth of the proteomics industry.

Dearth of skilled researchers

The field of proteomics requires skilled researchers as scientists need to perform the critical, time-consuming task to interpret their proteomics data and extract meaningful biological information from the multiple, complex data sets. There is a shortage of skilled scientists as the field of proteomics is relatively new and there is lack of knowledge as to what proteomics can achieve, which restrain the growth of proteomics. However, many organizations arrange training workshops to educate researchers regarding proteomics. For instance, EMBO Workshop was organized in Varna, Italy from 31 July to 06 August 2016 to educate postdoctoral scientists from academics and industry with insights into proteomic technologies and applications in the life sciences.

Key players in proteomics industry include Thermo Fisher Scientific Corporation, Agilent Technologies, Luminex Corporation, Danaher Corporation, Inc., Bio-Rad Laboratories, Inc., GE Healthcare, Waters Corporation, Caprion Proteomics Inc., and PerkinElmer, Inc.  Other players in the value chain include Quanterix Corporation, Courtagen Life Sciences, Inc., Sera Prognostics, Inc., Applied Proteomics, Inc., MRM Proteomics, Inc., Sonata Biosciences, Inc., Applied Biomics, Inc., Antigen Discovery, Inc., Bionexus, Inc., Correlia Biosystems, Inc., Digilab, Inc., GenScript Corporation, Creative Biogene and Proteome Sciences.

KEY MARKET BENEFITS OF PROTEOMICS MARKET:

  • The study provides an in-depth analysis of the global proteomics market with current trends and future estimations to elucidate the imminent investment pockets.

  • The report provides a quantitative analysis from 2014 to 2022, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.

  • Proteomics market analysis by components helps understand the various types of instruments used.

  • Competitive intelligence highlights the business practices followed by leading players across various regions.

  • Comprehensive analysis of all geographic regions is provided to determine the prevailing opportunities in these geographies.

  • Key market players are profiled in the report and their strategies are analyzed thoroughly, which interpret the competitive outlook of the global proteomics industry.

  • Extensive analysis of the proteomics market is conducted by closely following key product positioning and monitoring the top contenders within the market framework.

Proteomics Market Key Segments 

By Components

  • Instruments

    • Protein Microarray

    • Spectrometry

      • Mass Spectrometry

      • NMR Spectroscopy

    • Chromatography

      • HPLC Systems

      • Ion Chromatography

      • Affinity Chromatography

      • Supercritical Fluid Chromatography

    • Electrophoresis

      • Gel Electrophoresis

      • Capillary Electrophoresis

    • Surface Plasmon Resonance

    • X-ray Crystallography

    • Protein Fractionation Systems

  • Reagents

    • Microarray

    • Spectroscopy

    • X-Ray Crystallography

    • Chromatography

    • Electrophoresis

    • Immunoassay

    • Protein Fractionation Reagents

    • Services

By Application

  • Drug Discovery

  • Disease Diagnosis

  • Others

By Geography

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • Germany

    • France

    • U.K.

    • Italy

    • Spain

    • Rest of Europe

  • Asia-Pacific

    • Japan

    • China

    • India

    • South Korea

    • Australia

    • Rest of Asia-Pacific

  • LAMEA

    • Brazil

    • Israel

    • South Africa

    • Saudi Arabia

    • Rest of LAMEA

 

Chapter: 1 INTRODUCTION

1.1 Report description
1.2 Key benefits
1.3 Key market segments
1.4 Research methodology

1.4.1 Secondary research
1.4.2 Primary research
1.4.3 Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1 CXO perspective

Chapter: 3 MARKET OVERVIEW

3.1 Market definition & scope
3.2 Key findings

3.2.1 Top investment pockets
3.2.2 Top winning strategies

3.3 Recent developments in the field of proteomics

3.3.1 Two dimensional electrophoresis
3.3.2 Advances in mass spectrometry
3.3.3 Reagents and kits
3.3.4 Chromatography technology
3.3.5 Data analysis

3.4 Player positioning, 2015
3.5 Market Dynamics

3.5.1 Drivers

3.5.1.1 Increasing popularity of personalized medicine is driving the demand for proteomic technologies
3.5.1.2 Increasing research & development expenditure to drive the proteomics market
3.5.1.3 Technological advancements to drive the proteomics market
3.5.1.4 Proteomics help to bridge the gap between the understanding of genome expression and cellular behavior

3.5.2 Restraints

3.5.2.1 High cost of instruments
3.5.2.2 Dearth of skilled researchers

3.5.3 Opportunities

3.5.3.1 Developments in mass spectrometry-based proteomic strategies
3.5.3.2 Identification of biomarker offers significant opportunities

Chapter: 4 WORLD PROTEOMICS MARKET, BY COMPONENT

4.1 Overview

4.1.1 Market size and forecast

4.2 Instruments

4.2.1 Key market trends
4.2.2 Key growth factors and opportunities
4.2.3 Market size and forecast
4.2.4 Protein microarray
4.2.5 Spectrometry

4.2.5.1 Mass spectroscopy
4.2.5.2 NMR spectroscopy

4.2.6 Chromatography

4.2.6.1 HPLC systems
4.2.6.2 Ion chromatography
4.2.6.3 Affinity chromatography
4.2.6.4 Supercritical Fluid Chromatography

4.2.7 Electrophoresis

4.2.7.1 Gel electrophoresis
4.2.7.2 Capillary electrophoresis

4.2.8 Surface Plasmon Resonance
4.2.9 X-ray crystallography
4.2.10 Protein Fractionation Systems

4.3 Reagents

4.3.1 Key market trends
4.3.2 Key growth factors and opportunities
4.3.3 Market size and forecast
4.3.4 Microarray
4.3.5 Spectroscopy
4.3.6 X-Ray Crystallography
4.3.7 Chromatography
4.3.8 Electrophoresis
4.3.9 Immunoassay
4.3.10 Protein Fractionation Reagents

4.4 Services market

4.4.1 Key market trends
4.4.2 Key growth factors and opportunities
4.4.3 Market size and forecast

Chapter: 5 WORLD PROTEOMICS MARKET, BY APPLICATION, 2014-2022

5.1 Overview

5.1.1 Market size and forecast

5.2 Drug Discovery

5.2.1 Market size and forecast

5.3 Disease Diagnosis

5.3.1 Market size and forecast

5.4 Other Applications

5.4.1 Market size and forecast

Chapter: 6 WORLD PROTEOMICS MARKET, BY GEOGRAPHY, 2014-2022

6.1 Overview
6.2 North America

6.2.1 Key market trends
6.2.2 Key growth factors and opportunities
6.2.3 Market size and forecast
6.2.4 U.S.
6.2.5 Canada
6.2.6 Mexico

6.3 Europe

6.3.1 Key market trends
6.3.2 Key growth factors and opportunities
6.3.3 Market size and forecast
6.3.4 Germany
6.3.5 France
6.3.6 UK
6.3.7 Italy
6.3.8 Spain
6.3.9 Rest of Europe

6.4 Asia Pacific

6.4.1 Key market trends
6.4.2 Key growth factors and opportunities
6.4.3 Market size and forecast
6.4.4 Japan
6.4.5 China
6.4.6 India
6.4.7 South Korea
6.4.8 Australia
6.4.9 Rest of Asia-Pacific

6.5 LAMEA

6.5.1 Key market trends
6.5.2 Key growth factors and opportunities
6.5.3 Market size and forecast
6.5.4 Brazil
6.5.5 Isreal
6.5.6 Saudi Arabia
6.5.7 South Africa
6.5.8 Rest of LAMEA

Chapter: 7 COMPANY PROFILES

7.1 Agilent Technologies, Inc.

7.1.1 Company Overview
7.1.2 Company Snapshot
7.1.3 Operating business segments
7.1.4 Business performance
7.1.5 Key Strategic Moves & Developments

7.2 Bio-Rad Laboratories, Inc.

7.2.1 Company Overview
7.2.2 Company Snapshot
7.2.3 Operating business segments
7.2.4 Business performance

7.3 Bruker Corporation

7.3.1 Company Overview
7.3.2 Company Snapshot
7.3.3 Operating business segments
7.3.4 Business performance
7.3.5 Key Strategic Moves & Developments

7.4 Caprion Proteomics Inc.

7.4.1 Company Overview
7.4.2 Company Snapshot
7.4.3 Operating business segments

7.5 Danaher Corporation

7.5.1 Company Overview
7.5.2 Company Snapshot
7.5.3 Operating Business Segments
7.5.4 Business Performance
7.5.5 Key Strategic Moves & Developments

7.6 General Electric Co.

7.6.1 Company overview
7.6.2 GE: SNAPSHOT
7.6.3 Operating business segments overview
7.6.4 Business performance
7.6.5 Key Strategic moves & developments

7.7 LUMINEX CORPORATION

7.7.1 Company Overview
7.7.2 Company Snapshot
7.7.3 Operating business segments
7.7.4 Business performance
7.7.5 Key Strategic Moves & Developments

7.8 THERMO FISHER SCIENTIFIC INC.

7.8.1 Company Overview
7.8.2 Company Snapshot
7.8.3 Operating business segments
7.8.4 Business performance
7.8.5 Key Strategic Moves & Developments

7.9 Waters Corporation

7.9.1 Company Overview
7.9.2 Company Snapshot
7.9.3 Operating business segments
7.9.4 Business performance
7.9.5 Key Strategic Moves & Developments

7.10 PerkinElmer, Inc.

7.10.1 Company Overview
7.10.2 Company Snapshot
7.10.3 Operating business segments
7.10.4 Business performance

List of Figures

FIG. 1 TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION, 2012-2016
FIG. 2 PLAYER POSITIONING, 2015
FIG. 3 TOP IMPACTING FACTORS: WORLD PROTEOMICS MARKET, 2015-2022
FIG. 4 WORLD PROTEOMICS MARKET FOR PROTEIN MICROARRAY ($MILLION), 2014-2022
FIG. 5 WORLD PROTEOMICS MARKET FOR MASS SPECTROMETRY ($MILLION), 2014-2022
FIG. 6 WORLD PROTEOMICS MARKET FOR NMR SPECTROSCOPY ($MILLION), 2014-2022
FIG. 7 WORLD PROTEOMICS MARKET FOR HPLC SYSTEMS ($MILLION), 2014-2022
FIG. 8 WORLD PROTEOMICS MARKET FOR ION CHROMATOGRAPHY ($MILLION), 2014-2022
FIG. 9 WORLD PROTEOMICS MARKET FOR AFFINITY CHROMATOGRAPHY ($MILLION), 2014-2022
FIG. 10 WORLD PROTEOMICS MARKET FOR SUPERCRITICAL FLUID CHROMATOGRAPHY ($MILLION), 2014-2022
FIG. 11 WORLD PROTEOMICS MARKET FOR GEL ELECTROPHORESIS ($MILLION), 2014-2022
FIG. 12 WORLD PROTEOMICS MARKET FOR CAPILLARY ELECTROPHORESIS ($MILLION), 2014-2022
FIG. 13 WORLD PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE ($MILLION), 2014-2022
FIG. 14 WORLD PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY ($MILLION), 2014-2022
FIG. 15 WORLD PROTEOMICS MARKET FOR PROTEIN FRACTIONATION SYSTEMS ($MILLION), 2014-2022
FIG. 16 WORLD PROTEOMICS MARKET FOR MICROARRAY REAGENTS, 2014-2022 ($MILLION)
FIG. 17 WORLD PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS, 2014-2022 ($MILLION)
FIG. 18 WORLD PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS ($MILLION), 2014-2022
FIG. 19 WORLD PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS ($MILLION), 2014-2022
FIG. 20 WORLD PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS ($MILLION), 2014-2022
FIG. 21 WORLD PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS ($MILLION), 2014-2022
FIG. 22 WORLD PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS ($MILLION), 2014-2022
FIG. 23 WORLD PROTEOMICS MARKET FOR SERVICES ($MILLION), 2014-2022
FIG. 24 WORLD PROTEOMICS MARKET FOR DRUG DISCOVERY ($MILLION), 2014-2022
FIG. 25 WORLD PROTEOMICS MARKET FOR DISEASE DIAGNOSIS ($MILLION), 2014-2022
FIG. 26 WORLD PROTEOMICS MARKET FOR OTHER APPLICATIONS ($MILLION), 2014-2022
FIG. 27 U.S. PROTEOMICS MARKET ($MILLION), 2014-2022
FIG. 28 CANADA PROTEOMICS MARKET ($MILLION), 2014-2022
FIG. 29 MEXICO PROTEOMICS MARKET ($MILLION), 2014-2022
FIG. 30 GERMANY PROTEOMICS MARKET ($MILLION), 2014-2022
FIG. 31 FRANCE PROTEOMICS MARKET ($MILLION), 2014-2022
FIG. 32 UK PROTEOMICS MARKET ($MILLION), 2014-2022
FIG. 33 ITALY PROTEOMICS MARKET ($MILLION), 2014-2022
FIG. 34 SPAIN PROTEOMICS MARKET ($MILLION), 2014-2022
FIG. 35 REST OF EUROPE PROTEOMICS MARKET ($MILLION), 2014-2022
FIG. 36 JAPAN PROTEOMICS MARKET ($MILLION), 2014-2022
FIG. 37 CHINA PROTEOMICS MARKET ($MILLION), 2014-2022
FIG. 38 INDIA PROTEOMICS MARKET ($MILLION), 2014-2022
FIG. 39 SOUTH KOREA PROTEOMICS MARKET ($MILLION), 2014-2022
FIG. 40 AUSTRALIA PROTEOMICS MARKET ($MILLION), 2014-2022
FIG. 41 REST OF ASIA-PACIFC PROTEOMICS MARKET ($MILLION), 2014-2022
FIG. 42 BRAZIL PROTEOMICS MARKET ($MILLION), 2014-2022
FIG. 43 ISRAEL PROTEOMICS MARKET ($MILLION), 2014-2022
FIG. 44 SOUTH AFRICA PROTEOMICS MARKET ($MILLION), 2014-2022
FIG. 45 SAUDI ARABIA PROTEOMICS MARKET ($MILLION), 2014-2022
FIG. 46 REST OF LAMEA PROTEOMICS MARKET ($MILLION), 2014-2022
FIG. 47 AGILENT TECHNOLOGIES - NET SALES ($MILLION), 2013-2015
FIG. 48 AGILENT TECHNOLOGIES - NET SALES, BY SEGMENT, 2015 (%)
FIG. 49 AGILENT TECHNOLOGIES - NET SALES, BY GEOGRAPHY, 2015 (%)
FIG. 50 BIO-RAD - NET SALES, 2013-2015 ($MILLION)
FIG. 51 BIO-RAD - NET SALES, BY SEGMENT, 2015 (%)
FIG. 52 BIO-RAD - NET SALES, BY GEOGRAPHY, 2015 (%)
FIG. 53 BRUKER CORPORATION - NET SALES ($MILLION), 2013-2015
FIG. 54 BRUKER CORPORATION - NET SALES, BY SEGMENT, 2015 (%)
FIG. 55 BRUKER CORPORATION - NET SALES, BY GEOGRAPHY, 2015 (%)
FIG. 56 DANAHER - NET SALES ($MILLION), 2013-2015
FIG. 57 DANAHER - NET SALES, BY SEGMENT, 2015 (%)
FIG. 58 DANAHER - NET SALES, BY GEOGRAPHY, 2015 (%)
FIG. 59 GE - NET SALES ($MILLION), 2013-2015
FIG. 60 GE - NET SALES, BY SEGMENT, 2015 (%)
FIG. 61 GE - NET SALES, BY GEOGRAPHY, 2015 (%)
FIG. 62 LUMINEX - NET SALES ($MILLION), 201-2016
FIG. 63 LUMINEX - REVENUE, BY SEGMENT, 2016 (%)
FIG. 64 LUMINEX - NET SALES, BY GEOGRAPHY, 2016 (%)
FIG. 65 THERMO FISHER - NET SALES ($MILLION), 2013-2015
FIG. 66 THERMO FISHER - NET SALES, BY SEGMENT, 2015 (%)
FIG. 67 THERMO FISHER - NET SALES, BY GEOGRAPHY, 2015 (%)
FIG. 68 WATERS CORPORATION - NET SALES, ($MILLION), 2013-2015
FIG. 69 WATERS CORPORATION - NET SALES, BY SEGMENT, 2015 (%)
FIG. 70 WATERS CORPORATION - NET SALES, BY GEOGRAPHY, 2015 (%)
FIG. 71 PERKINELMER - TOTAL SALES ($MILLION), 2013-2015
FIG. 72 PERKINELMER - REVENUE, BY SEGMENT, 2015 (%)
FIG. 73 PERKINELMER - NET SALES, BY GEOGRAPHY, 2015 (%)

List of Tables

TABLE 1 WORLD PROTEOMICS MARKET, BY COMPONENT ($MILLION), 2014-2022
TABLE 2 WORLD PROTEOMICS MARKET FOR INSRUMENTS, BY TYPE ($MILLION), 2014-2022
TABLE 3 WORLD PROTEOMICS MARKET FOR SPECTROMETRY, BY TYPE ($MILLION), 2014-2022
TABLE 4 WORLD PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE ($MILLION), 2014-2022
TABLE 5 WORLD PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE ($MILLION), 2014-2022
TABLE 6 WORLD PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE ($MILLION), 2014-2022
TABLE 7 WORLD PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY ($MILLION), 2014-2022
TABLE 8 WORLD PROTEOMICS MARKET FOR PROTEIN FRACTIONATION SYSTEMS ($MILLION), 2014-2022
TABLE 9 WORLD PROTEOMICS MARKET FOR REAGENTS, BY TYPE ($MILLION), 2014-2022
TABLE 10 WORLD PROTEOMICS MARKET, BY APPLICATION ($MILLION), 2014-2022
TABLE 11 WORLD PROTEOMICS MARKET, BY REGION ($MILLION), 2014-2022
TABLE 12 WORLD PROTEOMICS MARKET FOR INSTRUMENTS, BY REGION ($MILLION), 2014-2022
TABLE 13 WORLD PROTEOMICS MARKET FOR REAGENTS, BY REGION ($MILLION), 2014-2022
TABLE 14 WORLD PROTEOMICS MARKET FOR SERVICES, BY REGION ($MILLION), 2014-2022
TABLE 15 NORTH AMERICA PROTEOMICS MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 16 NORTH AMERICA PROTEOMICS MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 17 EUROPE PROTEOMICS MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 18 EUROPE PROTEOMICS MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 19 ASIA-PACIFIC PROTEOMICS MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 20 ASIA-PACIFIC PROTEOMICS MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 21 LAMEA PROTEOMICS MARKET, BY TYPE ($MILLION), 2014-2022
TABLE 22 LAMEA PROTEOMICS MARKET, BY COUNTRY ($MILLION), 2014-2022
TABLE 23 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT
TABLE 24 AGILENT TECHNOLOGIES - OPERATING SEGMENTS
TABLE 25 BIO-RAD - COMPANY SNAPSHOT
TABLE 26 BIO-RAD - OPERATING SEGMENTS
TABLE 27 BRUKER CORPORATION - COMPANY SNAPSHOT
TABLE 28 BRUKER CORPORATION: OPERATING SEGMENTS
TABLE 29 CAPRION PROTEOMICS - COMPANY SNAPSHOT
TABLE 30 CAPRION - OPERATING SEGMENTS
TABLE 31 DANAHER - COMPANY SNAPSHOT
TABLE 32 DANAHER - OPERATING SEGMENTS
TABLE 33 GE - COMPANY SNAPSHOT
TABLE 34 GE: OPERATING SEGMENTS
TABLE 35 LUMINEX - COMPANY SNAPSHOT
TABLE 36 LUMINEX - OPERATING SEGMENTS
TABLE 37 THERMO FISHER - COMPANY SNAPSHOT
TABLE 38 THERMO FISHER - OPERATING SEGMENTS
TABLE 39 WATERS CORPORATION - COMPANY SNAPSHOT
TABLE 40 WATER CORPORATION - OPERATING SEGMENTS
TABLE 41 PERKINELMER - COMPANY SNAPSHOT
TABLE 42 PERKINELMER - OPERATING SEGMENTS

 
 

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

 
 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 
 

Purchase Full Report of
Proteomics Market- Global Opportunity Analysis and Industry Forecast, 2014-2022

  • Online Only
  • $3690
  • Online cloud Access only
  • Restected Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $4099
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $4999
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6004
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprice
    License/PDF

  • $8373
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  • Free quartery industry update
  • Free report update (Within 180 days)
  • Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts